Over a dozen publications from founder Dr. Andres Acosta, shows the improvement in weight loss for patients once classified by obesity phenotype. The knowledge gained through obesity phenotyping empowers physicians to treat individual patients using precision medicine.
The Obesity Journal recently published Dr. Acosta and team's pragmatic trial on obesity phenotyping and demonstrated a doubling of treatment responders, and twice as much weight loss for patients whose treatment is guided by their dominant obesity phenotype.
|Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study|
|Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial|
|Gastrointestinal traits: individualizing therapy for obesity with drugs and devices|
|Changes in Time of Gastric Emptying After Surgical and Endoscopic Bariatrics and Weight Loss: A Systematic Review and Meta-Analysis||Endoscopic Sleeve Gastroplasty Alters Gastric Physiology and Induces Loss of Body Weight in Obese Individuals|
|Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: Results of a prospective study|